ABL Bio Inc.’s (KOSDAQ:298380) stock price dropped 8.0% last week; individual investors would not be happy
Key Insights
- ABL Bio’s significant individual investors ownership suggests that the key decisions are influenced by shareholders from the larger public
- The top 14 shareholders own 50% of the company
- Insiders own 31% of ABL Bio
To get a sense of who is truly in control of ABL Bio Inc. (KOSDAQ:298380), it is important to understand the ownership structure of the business. And the group that holds the biggest piece of the pie are individual investors with 49% ownership. Put another way, the group faces the maximum upside potential (or downside risk).
While insiders, who own 31% shares weren’t spared from last…
